Eliquis’ European Label Supports Superiority Claims
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol and Pfizer expect to launch novel anticoagulant Eliquis within weeks in Germany and the U.K. following approval in Europe on Nov. 20. Eliquis looks well-positioned to compete in Europe with a label reflecting superiority on safety, efficacy for stroke prevention and mortality.